Mobia Medical
Restorative stroke recovery
We deliver breakthrough recovery solutions for stroke survivors. Our Vivistim® Paired VNS™ Therapy is the first and only clinically validated, FDA-approved solution for chronic ischemic stroke survivors with moderate to severe upper extremity impairment.
Mobilizing a better way forward in chronic stroke care
For too long, stroke survivors with life-altering motor impairments have had few meaningful options for lasting recovery. We exist to help chronic stroke survivors restore quality of life and regain independence, even months or years after a stroke.
A therapy designed for how the brain learns
Our Vivistim® Paired VNS™ Therapy combines targeted vagus nerve stimulation with functional activities to promote neuroplasticity, enabling the brain to create and strengthen neural connections for lasting improvements in motor pathways.
Creating new pathways for restorative recovery
We are establishing a new standard of care in chronic stroke recovery with the first and only FDA-approved solution for ischemic stroke patients with moderate to severe upper extremity impairment.
Mobia Medical culture
Driven by purpose and grounded in care.
At Mobia Medical, we’re forging new pathways for stroke survivors.
As a Quality team, we think about the people who rely on what we do—patients, clinicians, and our own teams. We set quality standards and make sure every product meets them, so Vivistim is safe, consistent, and ready to support recovery.
Mobia Medical News
There’s more to our story.
See how Mobia Medical is shaping the future of stroke recovery through recent news.
MicroTransponder Announces Corporate Name Change to Mobia Medical
MicroTransponder Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation
MicroTransponder Announces Positive Medicare Payment Change for Vivistim® Procedure
MicroTransponder Appoints Dana G. Mead, Jr. as Chair of the Board and Adds Cynthia Lucchese as Independent Director
Vivistim Co-Founder Named Innovator of the Year by the Congress of Neurological Surgeons
26-0015-0002 Rev. 0